Why the 503B vs 503A distinction matters for TRT clinics
PeakLifeRx connects clinics to FDA-registered 503B outsourcing facilities for clinic-inventory and office-use supply. That fits a clinic that stocks testosterone vials or ancillary compounds on the shelf for office use under 503B rules. When your clinic prescribes compounded testosterone and peptides for identified patients on individualized recurring protocols, that is 503A patient-specific compounding — a different regulatory model that requires one Rx per patient and per-line HIPAA audit.
PeakLifeRx also keeps catalog and pricing behind credential approval with volume-based quotes negotiated at onboarding. For a membership clinic that sets monthly patient pricing based on testosterone and peptide stack cost, not seeing per-vial landed cost before you commit is the central friction to confirm before signing.